Top compounds associated with response to CTC-429P9.4


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA triptolide CTRPv2 pan-cancer AAC -0.038 0.3
mRNA ML006 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA linifanib CTRPv2 pan-cancer AAC 0.038 0.3
mRNA PX-12 CTRPv2 pan-cancer AAC -0.03 0.3
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA ELCPK CTRPv2 pan-cancer AAC -0.053 0.3
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
Download CSV